The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
about
Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sitesDNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinomaGlobal mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes.Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.Protumoral roles of melanoma inhibitory activity 2 in oral squamous cell carcinomaDownregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity.A comprehensive expression analysis of the MIA gene family in malignancies: MIA gene family members are novel, useful markers of esophageal, lung, and cervical squamous cell carcinomaDown-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).Expression and function of methylthioadenosine phosphorylase in chronic liver disease.Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in miceAnalysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in miceUpdate of molecular pathobiology in oral cancer: a review.Long non-coding RNAs in cancer invasion and metastasis.Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma.Mechanisms for exporting large-sized cargoes from the endoplasmic reticulum.Regulation of hepatocyte identity and quiescence.Regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma.The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosisRecombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration.Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.A common genetic variation of melanoma inhibitory activity-2 labels a subtype of pancreatic adenocarcinoma with high endoplasmic reticulum stress levels.Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis.Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma.Hepatocyte nuclear factor 1β is a novel prognostic marker independent of the Milan criteria in transplantable hepatocellular carcinoma: a retrospective analysis based on tissue microarrays.Network-directed cis-mediator analysis of normal prostate tissue expression profiles reveals downstream regulatory associations of prostate cancer susceptibility loci.CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
P2860
Q24318609-421D7034-E341-49B3-9A95-DF4E25C5FF23Q28383720-563C0DE4-2EEB-4031-B81E-EB5D3245177EQ33347134-619B58D9-C22E-4A25-96E1-EF262DF49421Q33703786-A74D0064-6355-4F27-A987-3BAC2666941BQ34317898-3D83D14A-0F8B-48B1-9BEB-2AA46807EAE0Q34334079-9DA367BF-0BEC-40FD-B342-4F44BDA9EAE5Q34371623-83B485EC-5C54-4322-87A2-A7F1E7510AD8Q34524975-1237AAB6-B490-4BC3-B713-E509F12656E3Q34756307-F5EAF9C8-5364-448D-ADEE-6B44B70DAB76Q35063777-798DB63E-A5E4-4BEE-8205-9CE15E2E8409Q35532289-20550AAB-AE73-4499-BA5E-10D2CB3D5E9DQ37054565-2923FDA7-9996-47FD-8BC4-10E5FDDEDDB1Q37706542-9349E0C4-1383-463E-8A21-DD366172E857Q38198988-5D664578-E294-4BD1-B7A6-5CAB67995A22Q38219896-A264169E-9464-4415-97C6-C0A434C9C81EQ38332451-D691D969-217F-4D0E-A4A0-4B3D08ACCFF4Q38529922-7A69FE83-0C24-4DDA-9E0D-721E6E5CC137Q38531851-9E47F5AD-EA27-46FC-985B-6277C7386A2DQ39018915-AF8FA0EE-B2E8-4736-A065-0623E2BC3C63Q39129140-804305B2-0111-468D-B4FD-3C040CAFBF75Q39478349-0B7B38FD-4CE6-497F-83D8-5096C1E176E4Q39490669-64D335F2-4933-404A-9A08-52DC35627F9FQ39834604-240E5729-84CB-46F0-857F-DDD368D77D97Q39872802-838D2DC1-A6E7-457C-96AA-FA55E4A21277Q41813308-05BE4F08-21F3-4DCB-BF06-3EF9AAD6404DQ43189041-5A3C4DB6-B3FD-4D51-AEC0-985E15AA3512Q43676353-F78F6AD8-5037-4B71-8765-AF5E0F9D73CAQ44119630-4F5BFEC2-50D5-48E1-8BF0-699D8BBEEAA9Q47112493-3E0299AE-C809-44F4-9F7D-BB4982BDF7A7Q53248259-B4F7BC8F-B4A3-441E-93C6-CC5EE82FA738
P2860
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@ast
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@en
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@nl
type
label
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@ast
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@en
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@nl
prefLabel
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@ast
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@en
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@nl
P2093
P356
P1433
P1476
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
@en
P2093
Bataille F
Hartmann A
Hellerbrand C
Schlegel J
P304
P356
10.1136/GUT.2007.129544
P407
P577
2007-09-19T00:00:00Z